TY - JOUR
T1 - Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients
T2 - a randomised, double blind, crossover, placebo controlled study
AU - Szkudlarek, J
AU - Jeppesen, P B
AU - Mortensen, P B
PY - 2000/8
Y1 - 2000/8
N2 - BACKGROUND: High dose growth hormone, glutamine, and a high carbohydrate diet may improve intestinal function in short bowel patients.AIMS: To investigate if growth hormone with glutamine and no change in diet improved intestinal function.PATIENTS AND METHODS: Eight short bowel patients were randomised in a double blind crossover study between placebo and growth hormone (mean 0.12 mg/kg/day) with oral (mean 28 g/day) and parenteral glutamine (mean 5.2 g/day) for 28 days. Balance studies were performed at baseline and five days after placebo and treatment were terminated. Dietary energy, carbohydrate, and fat were maintained as usual.RESULTS: Growth hormone with glutamine did not improve intestinal absorption of energy (baseline, placebo, treatment, mean: 46%, 48%, 46% of oral intake, respectively), carbohydrate (71%, 70%, 71%), fat (20%, 15%, 18%), nitrogen (27%, 18%, 19%), wet weight (37%, 39%, 31%), sodium (-16%, -16%, -36%), potassium (43%, 47%, 33%), calcium (-16%, -16%, -15%) or magnesium (-3%, 4%, 2%) compared with placebo or baseline (p>0.05) five days after treatment was terminated. All patients experienced adverse effects.CONCLUSIONS: Combined high dose growth hormone and glutamine administered for four weeks did not improve intestinal absorption five days after treatment was terminated in short bowel patients on their usual diet.
AB - BACKGROUND: High dose growth hormone, glutamine, and a high carbohydrate diet may improve intestinal function in short bowel patients.AIMS: To investigate if growth hormone with glutamine and no change in diet improved intestinal function.PATIENTS AND METHODS: Eight short bowel patients were randomised in a double blind crossover study between placebo and growth hormone (mean 0.12 mg/kg/day) with oral (mean 28 g/day) and parenteral glutamine (mean 5.2 g/day) for 28 days. Balance studies were performed at baseline and five days after placebo and treatment were terminated. Dietary energy, carbohydrate, and fat were maintained as usual.RESULTS: Growth hormone with glutamine did not improve intestinal absorption of energy (baseline, placebo, treatment, mean: 46%, 48%, 46% of oral intake, respectively), carbohydrate (71%, 70%, 71%), fat (20%, 15%, 18%), nitrogen (27%, 18%, 19%), wet weight (37%, 39%, 31%), sodium (-16%, -16%, -36%), potassium (43%, 47%, 33%), calcium (-16%, -16%, -15%) or magnesium (-3%, 4%, 2%) compared with placebo or baseline (p>0.05) five days after treatment was terminated. All patients experienced adverse effects.CONCLUSIONS: Combined high dose growth hormone and glutamine administered for four weeks did not improve intestinal absorption five days after treatment was terminated in short bowel patients on their usual diet.
KW - Adult
KW - Aged
KW - Cross-Over Studies
KW - Diet
KW - Double-Blind Method
KW - Female
KW - Glutamine/administration & dosage
KW - Growth Hormone/therapeutic use
KW - Humans
KW - Intestinal Absorption/drug effects
KW - Male
KW - Middle Aged
KW - Short Bowel Syndrome/drug therapy
KW - Treatment Outcome
KW - Water-Electrolyte Imbalance/chemically induced
KW - Weight Gain/drug effects
U2 - 10.1136/gut.47.2.199
DO - 10.1136/gut.47.2.199
M3 - Journal article
C2 - 10896910
SN - 0017-5749
VL - 47
SP - 199
EP - 205
JO - Gut
JF - Gut
IS - 2
ER -